nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—NR3C1—type 2 diabetes mellitus	0.26	0.633	CbGaD
Podofilox—CYP3A4—type 2 diabetes mellitus	0.151	0.367	CbGaD
Podofilox—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0425	0.108	CbGbCtD
Podofilox—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0362	0.0918	CbGbCtD
Podofilox—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0362	0.0918	CbGbCtD
Podofilox—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0334	0.0847	CbGbCtD
Podofilox—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0322	0.0818	CbGbCtD
Podofilox—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0271	0.0689	CbGbCtD
Podofilox—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0242	0.0614	CbGbCtD
Podofilox—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0221	0.0561	CbGbCtD
Podofilox—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0193	0.0491	CbGbCtD
Podofilox—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0185	0.047	CbGbCtD
Podofilox—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0175	0.0444	CbGbCtD
Podofilox—CYP2C19—Losartan—type 2 diabetes mellitus	0.0169	0.043	CbGbCtD
Podofilox—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0132	0.0336	CbGbCtD
Podofilox—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0127	0.0322	CbGbCtD
Podofilox—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0127	0.0322	CbGbCtD
Podofilox—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.012	0.0305	CbGbCtD
Podofilox—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00895	0.0227	CbGbCtD
Podofilox—Balanoposthitis—Gliclazide—type 2 diabetes mellitus	0.00878	0.0937	CcSEcCtD
Podofilox—CYP3A4—Losartan—type 2 diabetes mellitus	0.00818	0.0208	CbGbCtD
Podofilox—Localized exfoliation—Losartan—type 2 diabetes mellitus	0.00254	0.0271	CcSEcCtD
Podofilox—Skin exfoliation—Linagliptin—type 2 diabetes mellitus	0.0019	0.0203	CcSEcCtD
Podofilox—TUBA4A—islet of Langerhans—type 2 diabetes mellitus	0.00183	0.0751	CbGeAlD
Podofilox—TUBA4A—retina—type 2 diabetes mellitus	0.00156	0.0642	CbGeAlD
Podofilox—TUBA4A—nephron tubule—type 2 diabetes mellitus	0.00147	0.0605	CbGeAlD
Podofilox—Tingling sensation—Bromocriptine—type 2 diabetes mellitus	0.0014	0.0149	CcSEcCtD
Podofilox—TUBB—islet of Langerhans—type 2 diabetes mellitus	0.00134	0.0551	CbGeAlD
Podofilox—TUBA4A—cardiovascular system—type 2 diabetes mellitus	0.00132	0.0543	CbGeAlD
Podofilox—TUBA4A—kidney—type 2 diabetes mellitus	0.00129	0.0532	CbGeAlD
Podofilox—TUBA4A—pancreas—type 2 diabetes mellitus	0.00128	0.0528	CbGeAlD
Podofilox—NR3C1—nerve—type 2 diabetes mellitus	0.00128	0.0527	CbGeAlD
Podofilox—TUBA4A—cortex of kidney—type 2 diabetes mellitus	0.00126	0.0518	CbGeAlD
Podofilox—Skin ulcer—Gliclazide—type 2 diabetes mellitus	0.00118	0.0126	CcSEcCtD
Podofilox—TUBA4A—adipose tissue—type 2 diabetes mellitus	0.00116	0.0479	CbGeAlD
Podofilox—TUBB—nephron tubule—type 2 diabetes mellitus	0.00108	0.0443	CbGeAlD
Podofilox—Etoposide—ABCC2—type 2 diabetes mellitus	0.00101	0.26	CrCbGaD
Podofilox—Erythema—Tolbutamide—type 2 diabetes mellitus	0.000965	0.0103	CcSEcCtD
Podofilox—Dermatitis bullous—Glimepiride—type 2 diabetes mellitus	0.000944	0.0101	CcSEcCtD
Podofilox—TUBB—pancreas—type 2 diabetes mellitus	0.000941	0.0387	CbGeAlD
Podofilox—TUBA4A—Glipizide—Tolazamide—type 2 diabetes mellitus	0.000932	0.177	CbGdCrCtD
Podofilox—TUBA4A—Glipizide—Glimepiride—type 2 diabetes mellitus	0.000932	0.177	CbGdCrCtD
Podofilox—TUBB—cortex of kidney—type 2 diabetes mellitus	0.000922	0.0379	CbGeAlD
Podofilox—Immune system disorder—Linagliptin—type 2 diabetes mellitus	0.000902	0.00963	CcSEcCtD
Podofilox—TUBA4A—Glipizide—Gliclazide—type 2 diabetes mellitus	0.000883	0.168	CbGdCrCtD
Podofilox—TUBA4A—Glipizide—Tolbutamide—type 2 diabetes mellitus	0.000883	0.168	CbGdCrCtD
Podofilox—Erythema—Tolazamide—type 2 diabetes mellitus	0.000878	0.00938	CcSEcCtD
Podofilox—Immune system disorder—Acarbose—type 2 diabetes mellitus	0.000875	0.00935	CcSEcCtD
Podofilox—TOP2A—adipose tissue—type 2 diabetes mellitus	0.000861	0.0354	CbGeAlD
Podofilox—TUBB—adipose tissue—type 2 diabetes mellitus	0.000853	0.0351	CbGeAlD
Podofilox—Stinging—Losartan—type 2 diabetes mellitus	0.000844	0.00902	CcSEcCtD
Podofilox—Immune system disorder—Nateglinide—type 2 diabetes mellitus	0.000844	0.00901	CcSEcCtD
Podofilox—Erythema—Acarbose—type 2 diabetes mellitus	0.000843	0.00901	CcSEcCtD
Podofilox—Tenderness—Irbesartan—type 2 diabetes mellitus	0.000833	0.0089	CcSEcCtD
Podofilox—TUBA4A—liver—type 2 diabetes mellitus	0.000817	0.0336	CbGeAlD
Podofilox—TUBA4A—Glipizide—Chlorpropamide—type 2 diabetes mellitus	0.000808	0.154	CbGdCrCtD
Podofilox—Dermatitis bullous—Glyburide—type 2 diabetes mellitus	0.000779	0.00832	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Linagliptin—type 2 diabetes mellitus	0.000735	0.00785	CcSEcCtD
Podofilox—Immune system disorder—Repaglinide—type 2 diabetes mellitus	0.00073	0.0078	CcSEcCtD
Podofilox—Etoposide—CYP2E1—type 2 diabetes mellitus	0.000705	0.183	CrCbGaD
Podofilox—Erythema—Repaglinide—type 2 diabetes mellitus	0.000704	0.00752	CcSEcCtD
Podofilox—Swelling—Valsartan—type 2 diabetes mellitus	0.000696	0.00743	CcSEcCtD
Podofilox—Immune system disorder—Rosiglitazone—type 2 diabetes mellitus	0.00069	0.00737	CcSEcCtD
Podofilox—Skin disorder—Linagliptin—type 2 diabetes mellitus	0.000689	0.00736	CcSEcCtD
Podofilox—Oedema—Acarbose—type 2 diabetes mellitus	0.000688	0.00735	CcSEcCtD
Podofilox—Haematuria—Pioglitazone—type 2 diabetes mellitus	0.000681	0.00727	CcSEcCtD
Podofilox—Etoposide—CYP1A2—type 2 diabetes mellitus	0.000671	0.174	CrCbGaD
Podofilox—Skin exfoliation—Losartan—type 2 diabetes mellitus	0.000653	0.00698	CcSEcCtD
Podofilox—Dermatitis bullous—Valsartan—type 2 diabetes mellitus	0.000642	0.00686	CcSEcCtD
Podofilox—Dermatitis bullous—Orlistat—type 2 diabetes mellitus	0.000635	0.00678	CcSEcCtD
Podofilox—NR3C1—islet of Langerhans—type 2 diabetes mellitus	0.00062	0.0255	CbGeAlD
Podofilox—Dry skin—Gliclazide—type 2 diabetes mellitus	0.000613	0.00654	CcSEcCtD
Podofilox—TUBA4A—Glipizide—Glyburide—type 2 diabetes mellitus	0.000612	0.116	CbGdCrCtD
Podofilox—Teniposide—CYP3A4—type 2 diabetes mellitus	0.000599	0.155	CrCbGaD
Podofilox—TUBB—liver—type 2 diabetes mellitus	0.000599	0.0246	CbGeAlD
Podofilox—Swelling—Irbesartan—type 2 diabetes mellitus	0.000598	0.00639	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Repaglinide—type 2 diabetes mellitus	0.000595	0.00636	CcSEcCtD
Podofilox—Erythema—Glipizide—type 2 diabetes mellitus	0.000582	0.00622	CcSEcCtD
Podofilox—Immune system disorder—Pioglitazone—type 2 diabetes mellitus	0.000579	0.00618	CcSEcCtD
Podofilox—Oedema—Repaglinide—type 2 diabetes mellitus	0.000575	0.00614	CcSEcCtD
Podofilox—Swelling—Losartan—type 2 diabetes mellitus	0.000563	0.00601	CcSEcCtD
Podofilox—Immune system disorder—Sitagliptin—type 2 diabetes mellitus	0.000562	0.006	CcSEcCtD
Podofilox—Skin disorder—Repaglinide—type 2 diabetes mellitus	0.000558	0.00596	CcSEcCtD
Podofilox—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.000557	0.00595	CcSEcCtD
Podofilox—Dry skin—Orlistat—type 2 diabetes mellitus	0.000556	0.00594	CcSEcCtD
Podofilox—Rash—Miglitol—type 2 diabetes mellitus	0.000552	0.0059	CcSEcCtD
Podofilox—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000552	0.00589	CcSEcCtD
Podofilox—Erythema—Glimepiride—type 2 diabetes mellitus	0.000544	0.00581	CcSEcCtD
Podofilox—Oedema—Rosiglitazone—type 2 diabetes mellitus	0.000543	0.0058	CcSEcCtD
Podofilox—Paraesthesia—Repaglinide—type 2 diabetes mellitus	0.000516	0.00551	CcSEcCtD
Podofilox—Pruritus—Tolazamide—type 2 diabetes mellitus	0.000507	0.00541	CcSEcCtD
Podofilox—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.000507	0.00541	CcSEcCtD
Podofilox—NR3C1—nephron tubule—type 2 diabetes mellitus	0.000499	0.0205	CbGeAlD
Podofilox—Rash—Tolbutamide—type 2 diabetes mellitus	0.000497	0.0053	CcSEcCtD
Podofilox—Headache—Tolbutamide—type 2 diabetes mellitus	0.000493	0.00527	CcSEcCtD
Podofilox—Oedema—Glipizide—type 2 diabetes mellitus	0.000475	0.00508	CcSEcCtD
Podofilox—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000474	0.00506	CcSEcCtD
Podofilox—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000474	0.00506	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.000472	0.00504	CcSEcCtD
Podofilox—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00047	0.00502	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.000458	0.00489	CcSEcCtD
Podofilox—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000456	0.00487	CcSEcCtD
Podofilox—Oedema—Pioglitazone—type 2 diabetes mellitus	0.000455	0.00486	CcSEcCtD
Podofilox—Dry skin—Losartan—type 2 diabetes mellitus	0.000455	0.00486	CcSEcCtD
Podofilox—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000452	0.00483	CcSEcCtD
Podofilox—Rash—Tolazamide—type 2 diabetes mellitus	0.000452	0.00483	CcSEcCtD
Podofilox—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000449	0.00479	CcSEcCtD
Podofilox—Headache—Tolazamide—type 2 diabetes mellitus	0.000449	0.00479	CcSEcCtD
Podofilox—NR3C1—cardiovascular system—type 2 diabetes mellitus	0.000448	0.0185	CbGeAlD
Podofilox—Erythema—Glyburide—type 2 diabetes mellitus	0.000448	0.00479	CcSEcCtD
Podofilox—Rash—Linagliptin—type 2 diabetes mellitus	0.000447	0.00478	CcSEcCtD
Podofilox—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000447	0.00477	CcSEcCtD
Podofilox—Headache—Linagliptin—type 2 diabetes mellitus	0.000444	0.00474	CcSEcCtD
Podofilox—Etoposide—CYP3A4—type 2 diabetes mellitus	0.000444	0.115	CrCbGaD
Podofilox—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.000442	0.00472	CcSEcCtD
Podofilox—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000439	0.00469	CcSEcCtD
Podofilox—NR3C1—kidney—type 2 diabetes mellitus	0.000439	0.0181	CbGeAlD
Podofilox—Vomiting—Acarbose—type 2 diabetes mellitus	0.000438	0.00467	CcSEcCtD
Podofilox—NR3C1—pancreas—type 2 diabetes mellitus	0.000436	0.0179	CbGeAlD
Podofilox—Etoposide—PTGS2—type 2 diabetes mellitus	0.000435	0.113	CrCbGaD
Podofilox—Rash—Acarbose—type 2 diabetes mellitus	0.000434	0.00464	CcSEcCtD
Podofilox—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000434	0.00463	CcSEcCtD
Podofilox—Insomnia—Glipizide—type 2 diabetes mellitus	0.00043	0.00459	CcSEcCtD
Podofilox—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.00043	0.00459	CcSEcCtD
Podofilox—NR3C1—cortex of kidney—type 2 diabetes mellitus	0.000427	0.0176	CbGeAlD
Podofilox—Haemoglobin—Valsartan—type 2 diabetes mellitus	0.000427	0.00456	CcSEcCtD
Podofilox—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.000427	0.00456	CcSEcCtD
Podofilox—Haemorrhage—Valsartan—type 2 diabetes mellitus	0.000425	0.00454	CcSEcCtD
Podofilox—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000422	0.00451	CcSEcCtD
Podofilox—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.000422	0.00451	CcSEcCtD
Podofilox—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.00042	0.00448	CcSEcCtD
Podofilox—Rash—Nateglinide—type 2 diabetes mellitus	0.000419	0.00447	CcSEcCtD
Podofilox—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000418	0.00447	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.000415	0.00443	CcSEcCtD
Podofilox—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000412	0.0044	CcSEcCtD
Podofilox—Pain—Glipizide—type 2 diabetes mellitus	0.000406	0.00434	CcSEcCtD
Podofilox—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000406	0.00434	CcSEcCtD
Podofilox—Erythema—Gliclazide—type 2 diabetes mellitus	0.000403	0.0043	CcSEcCtD
Podofilox—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000401	0.00429	CcSEcCtD
Podofilox—Oedema—Bromocriptine—type 2 diabetes mellitus	0.0004	0.00427	CcSEcCtD
Podofilox—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.0004	0.00427	CcSEcCtD
Podofilox—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.000398	0.00425	CcSEcCtD
Podofilox—NR3C1—adipose tissue—type 2 diabetes mellitus	0.000395	0.0163	CbGeAlD
Podofilox—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000389	0.00415	CcSEcCtD
Podofilox—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000384	0.0041	CcSEcCtD
Podofilox—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000384	0.0041	CcSEcCtD
Podofilox—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.000379	0.00405	CcSEcCtD
Podofilox—Pain—Sitagliptin—type 2 diabetes mellitus	0.000378	0.00404	CcSEcCtD
Podofilox—Oedema—Glyburide—type 2 diabetes mellitus	0.000366	0.00391	CcSEcCtD
Podofilox—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000365	0.0039	CcSEcCtD
Podofilox—Rash—Repaglinide—type 2 diabetes mellitus	0.000362	0.00387	CcSEcCtD
Podofilox—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000362	0.00387	CcSEcCtD
Podofilox—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000362	0.00387	CcSEcCtD
Podofilox—Headache—Repaglinide—type 2 diabetes mellitus	0.00036	0.00384	CcSEcCtD
Podofilox—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000359	0.00384	CcSEcCtD
Podofilox—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000359	0.00384	CcSEcCtD
Podofilox—CYP2C19—liver—type 2 diabetes mellitus	0.000355	0.0146	CbGeAlD
Podofilox—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000349	0.00373	CcSEcCtD
Podofilox—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000342	0.00366	CcSEcCtD
Podofilox—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000342	0.00365	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00034	0.00363	CcSEcCtD
Podofilox—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00034	0.00363	CcSEcCtD
Podofilox—Erythema—Metformin—type 2 diabetes mellitus	0.000337	0.0036	CcSEcCtD
Podofilox—Pruritus—Glipizide—type 2 diabetes mellitus	0.000336	0.00359	CcSEcCtD
Podofilox—CYP3A4—kidney—type 2 diabetes mellitus	0.000332	0.0137	CbGeAlD
Podofilox—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.00033	0.00352	CcSEcCtD
Podofilox—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000329	0.00351	CcSEcCtD
Podofilox—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000319	0.00341	CcSEcCtD
Podofilox—Erythema—Irbesartan—type 2 diabetes mellitus	0.000318	0.00339	CcSEcCtD
Podofilox—Dizziness—Glipizide—type 2 diabetes mellitus	0.000314	0.00336	CcSEcCtD
Podofilox—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000314	0.00335	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000313	0.00334	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000309	0.0033	CcSEcCtD
Podofilox—Vomiting—Glipizide—type 2 diabetes mellitus	0.000302	0.00323	CcSEcCtD
Podofilox—Oedema—Valsartan—type 2 diabetes mellitus	0.000302	0.00322	CcSEcCtD
Podofilox—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000301	0.00322	CcSEcCtD
Podofilox—Rash—Glipizide—type 2 diabetes mellitus	0.0003	0.0032	CcSEcCtD
Podofilox—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000299	0.0032	CcSEcCtD
Podofilox—Erythema—Losartan—type 2 diabetes mellitus	0.000299	0.00319	CcSEcCtD
Podofilox—Oedema—Orlistat—type 2 diabetes mellitus	0.000298	0.00319	CcSEcCtD
Podofilox—Headache—Glipizide—type 2 diabetes mellitus	0.000298	0.00318	CcSEcCtD
Podofilox—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000297	0.00317	CcSEcCtD
Podofilox—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000295	0.00315	CcSEcCtD
Podofilox—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000293	0.00313	CcSEcCtD
Podofilox—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000293	0.00313	CcSEcCtD
Podofilox—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000292	0.00312	CcSEcCtD
Podofilox—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00029	0.00309	CcSEcCtD
Podofilox—Headache—Pioglitazone—type 2 diabetes mellitus	0.000285	0.00305	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000285	0.00304	CcSEcCtD
Podofilox—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000282	0.00301	CcSEcCtD
Podofilox—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000281	0.003	CcSEcCtD
Podofilox—Pain—Gliclazide—type 2 diabetes mellitus	0.000281	0.003	CcSEcCtD
Podofilox—Rash—Glimepiride—type 2 diabetes mellitus	0.00028	0.00299	CcSEcCtD
Podofilox—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000279	0.00298	CcSEcCtD
Podofilox—Rash—Sitagliptin—type 2 diabetes mellitus	0.000279	0.00298	CcSEcCtD
Podofilox—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000279	0.00298	CcSEcCtD
Podofilox—Headache—Glimepiride—type 2 diabetes mellitus	0.000278	0.00297	CcSEcCtD
Podofilox—NR3C1—liver—type 2 diabetes mellitus	0.000277	0.0114	CbGeAlD
Podofilox—Headache—Sitagliptin—type 2 diabetes mellitus	0.000277	0.00296	CcSEcCtD
Podofilox—Oedema—Metformin—type 2 diabetes mellitus	0.000275	0.00294	CcSEcCtD
Podofilox—Insomnia—Valsartan—type 2 diabetes mellitus	0.000273	0.00292	CcSEcCtD
Podofilox—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000271	0.00289	CcSEcCtD
Podofilox—Insomnia—Orlistat—type 2 diabetes mellitus	0.00027	0.00288	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000269	0.00287	CcSEcCtD
Podofilox—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000268	0.00286	CcSEcCtD
Podofilox—Skin disorder—Metformin—type 2 diabetes mellitus	0.000267	0.00285	CcSEcCtD
Podofilox—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000266	0.00284	CcSEcCtD
Podofilox—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000265	0.00283	CcSEcCtD
Podofilox—Oedema—Irbesartan—type 2 diabetes mellitus	0.000259	0.00277	CcSEcCtD
Podofilox—Pruritus—Glyburide—type 2 diabetes mellitus	0.000259	0.00276	CcSEcCtD
Podofilox—Erythema—Ramipril—type 2 diabetes mellitus	0.000256	0.00274	CcSEcCtD
Podofilox—Pain—Orlistat—type 2 diabetes mellitus	0.000255	0.00272	CcSEcCtD
Podofilox—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000254	0.00272	CcSEcCtD
Podofilox—Rash—Bromocriptine—type 2 diabetes mellitus	0.000252	0.00269	CcSEcCtD
Podofilox—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000252	0.00269	CcSEcCtD
Podofilox—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000252	0.00269	CcSEcCtD
Podofilox—Headache—Bromocriptine—type 2 diabetes mellitus	0.000251	0.00268	CcSEcCtD
Podofilox—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000247	0.00264	CcSEcCtD
Podofilox—Oedema—Losartan—type 2 diabetes mellitus	0.000244	0.00261	CcSEcCtD
Podofilox—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000233	0.00249	CcSEcCtD
Podofilox—Vomiting—Glyburide—type 2 diabetes mellitus	0.000233	0.00248	CcSEcCtD
Podofilox—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000232	0.00248	CcSEcCtD
Podofilox—Rash—Glyburide—type 2 diabetes mellitus	0.000231	0.00246	CcSEcCtD
Podofilox—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00023	0.00246	CcSEcCtD
Podofilox—Headache—Glyburide—type 2 diabetes mellitus	0.000229	0.00245	CcSEcCtD
Podofilox—Pain—Irbesartan—type 2 diabetes mellitus	0.000222	0.00237	CcSEcCtD
Podofilox—Insomnia—Losartan—type 2 diabetes mellitus	0.000221	0.00236	CcSEcCtD
Podofilox—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000219	0.00234	CcSEcCtD
Podofilox—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000217	0.00232	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000217	0.00232	CcSEcCtD
Podofilox—Pruritus—Valsartan—type 2 diabetes mellitus	0.000214	0.00228	CcSEcCtD
Podofilox—Pruritus—Orlistat—type 2 diabetes mellitus	0.000211	0.00225	CcSEcCtD
Podofilox—CYP3A4—liver—type 2 diabetes mellitus	0.00021	0.00863	CbGeAlD
Podofilox—Oedema—Ramipril—type 2 diabetes mellitus	0.000209	0.00224	CcSEcCtD
Podofilox—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000209	0.00223	CcSEcCtD
Podofilox—Pain—Losartan—type 2 diabetes mellitus	0.000209	0.00223	CcSEcCtD
Podofilox—Rash—Gliclazide—type 2 diabetes mellitus	0.000207	0.00221	CcSEcCtD
Podofilox—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000207	0.00221	CcSEcCtD
Podofilox—Headache—Gliclazide—type 2 diabetes mellitus	0.000206	0.0022	CcSEcCtD
Podofilox—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000203	0.00217	CcSEcCtD
Podofilox—Dizziness—Valsartan—type 2 diabetes mellitus	0.0002	0.00213	CcSEcCtD
Podofilox—Dizziness—Orlistat—type 2 diabetes mellitus	0.000197	0.00211	CcSEcCtD
Podofilox—Pruritus—Metformin—type 2 diabetes mellitus	0.000194	0.00208	CcSEcCtD
Podofilox—Vomiting—Valsartan—type 2 diabetes mellitus	0.000192	0.00205	CcSEcCtD
Podofilox—Rash—Valsartan—type 2 diabetes mellitus	0.00019	0.00203	CcSEcCtD
Podofilox—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00019	0.00203	CcSEcCtD
Podofilox—Vomiting—Orlistat—type 2 diabetes mellitus	0.00019	0.00203	CcSEcCtD
Podofilox—Insomnia—Ramipril—type 2 diabetes mellitus	0.000189	0.00202	CcSEcCtD
Podofilox—Headache—Valsartan—type 2 diabetes mellitus	0.000189	0.00202	CcSEcCtD
Podofilox—Rash—Orlistat—type 2 diabetes mellitus	0.000188	0.00201	CcSEcCtD
Podofilox—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000188	0.00201	CcSEcCtD
Podofilox—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000188	0.00201	CcSEcCtD
Podofilox—Headache—Orlistat—type 2 diabetes mellitus	0.000187	0.002	CcSEcCtD
Podofilox—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000184	0.00196	CcSEcCtD
Podofilox—Dizziness—Metformin—type 2 diabetes mellitus	0.000182	0.00194	CcSEcCtD
Podofilox—Vomiting—Metformin—type 2 diabetes mellitus	0.000175	0.00187	CcSEcCtD
Podofilox—Rash—Metformin—type 2 diabetes mellitus	0.000173	0.00185	CcSEcCtD
Podofilox—Dermatitis—Metformin—type 2 diabetes mellitus	0.000173	0.00185	CcSEcCtD
Podofilox—Pruritus—Losartan—type 2 diabetes mellitus	0.000173	0.00184	CcSEcCtD
Podofilox—Headache—Metformin—type 2 diabetes mellitus	0.000172	0.00184	CcSEcCtD
Podofilox—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000172	0.00183	CcSEcCtD
Podofilox—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000165	0.00176	CcSEcCtD
Podofilox—Rash—Irbesartan—type 2 diabetes mellitus	0.000164	0.00175	CcSEcCtD
Podofilox—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000163	0.00174	CcSEcCtD
Podofilox—Headache—Irbesartan—type 2 diabetes mellitus	0.000162	0.00174	CcSEcCtD
Podofilox—Dizziness—Losartan—type 2 diabetes mellitus	0.000161	0.00172	CcSEcCtD
Podofilox—Vomiting—Losartan—type 2 diabetes mellitus	0.000155	0.00166	CcSEcCtD
Podofilox—Rash—Losartan—type 2 diabetes mellitus	0.000154	0.00164	CcSEcCtD
Podofilox—Dermatitis—Losartan—type 2 diabetes mellitus	0.000154	0.00164	CcSEcCtD
Podofilox—Headache—Losartan—type 2 diabetes mellitus	0.000153	0.00163	CcSEcCtD
Podofilox—TOP2A—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.000151	0.0286	CbGdCrCtD
Podofilox—Pruritus—Ramipril—type 2 diabetes mellitus	0.000148	0.00158	CcSEcCtD
Podofilox—Dizziness—Ramipril—type 2 diabetes mellitus	0.000138	0.00148	CcSEcCtD
Podofilox—Vomiting—Ramipril—type 2 diabetes mellitus	0.000133	0.00142	CcSEcCtD
Podofilox—Rash—Ramipril—type 2 diabetes mellitus	0.000132	0.00141	CcSEcCtD
Podofilox—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000132	0.00141	CcSEcCtD
Podofilox—Headache—Ramipril—type 2 diabetes mellitus	0.000131	0.0014	CcSEcCtD
Podofilox—TOP2A—Bortezomib—Nateglinide—type 2 diabetes mellitus	5.73e-05	0.0109	CbGdCrCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	3.71e-05	0.000549	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	3.69e-05	0.000545	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	3.64e-05	0.000538	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—PPP2CA—type 2 diabetes mellitus	3.63e-05	0.000537	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	3.59e-05	0.000531	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	3.47e-05	0.000512	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	3.44e-05	0.000508	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	3.43e-05	0.000507	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	3.43e-05	0.000507	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	3.43e-05	0.000507	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—PRKCB—type 2 diabetes mellitus	3.42e-05	0.000506	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	3.4e-05	0.000503	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN2A—type 2 diabetes mellitus	3.4e-05	0.000502	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	3.37e-05	0.000498	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTM1—type 2 diabetes mellitus	3.34e-05	0.000494	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	3.32e-05	0.00049	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	3.3e-05	0.000487	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	3.24e-05	0.000478	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	3.21e-05	0.000475	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	3.21e-05	0.000475	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—SRC—type 2 diabetes mellitus	3.2e-05	0.000473	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	3.17e-05	0.000469	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	3.17e-05	0.000468	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	3.14e-05	0.000464	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—VEGFA—type 2 diabetes mellitus	3.12e-05	0.000461	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	3.11e-05	0.00046	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	3.11e-05	0.000459	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	3.1e-05	0.000457	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—PRKCB—type 2 diabetes mellitus	3.06e-05	0.000452	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	3.06e-05	0.000451	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	2.93e-05	0.000432	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	2.92e-05	0.000431	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	2.89e-05	0.000427	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TGFB1—type 2 diabetes mellitus	2.86e-05	0.000423	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—IL6—type 2 diabetes mellitus	2.69e-05	0.000397	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN2A—type 2 diabetes mellitus	2.66e-05	0.000393	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	2.65e-05	0.000392	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	2.62e-05	0.000387	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	2.62e-05	0.000386	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	2.6e-05	0.000384	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	2.6e-05	0.000384	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	2.59e-05	0.000382	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	2.58e-05	0.000381	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—BHMT—type 2 diabetes mellitus	2.55e-05	0.000377	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	2.5e-05	0.000369	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	2.41e-05	0.000355	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN2A—type 2 diabetes mellitus	2.38e-05	0.000351	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	2.33e-05	0.000345	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AANAT—type 2 diabetes mellitus	2.23e-05	0.000329	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGDS—type 2 diabetes mellitus	2.23e-05	0.000329	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	2.2e-05	0.000326	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	2.12e-05	0.000313	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CDO1—type 2 diabetes mellitus	2.11e-05	0.000312	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GPD2—type 2 diabetes mellitus	2.11e-05	0.000312	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	2.06e-05	0.000305	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	2.05e-05	0.000303	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	2.02e-05	0.000298	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AK1—type 2 diabetes mellitus	2.02e-05	0.000298	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.01e-05	0.000297	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.99e-05	0.000294	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—AKT1—type 2 diabetes mellitus	1.99e-05	0.000294	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	1.99e-05	0.000294	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	1.98e-05	0.000293	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	1.93e-05	0.000285	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	1.93e-05	0.000285	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	1.89e-05	0.000279	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC5A4—type 2 diabetes mellitus	1.86e-05	0.000275	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MAT1A—type 2 diabetes mellitus	1.86e-05	0.000275	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.85e-05	0.000274	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.82e-05	0.000268	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.8e-05	0.000266	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ND1—type 2 diabetes mellitus	1.8e-05	0.000265	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ENPP1—type 2 diabetes mellitus	1.8e-05	0.000265	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—G6PC—type 2 diabetes mellitus	1.8e-05	0.000265	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.8e-05	0.000265	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HBA2—type 2 diabetes mellitus	1.8e-05	0.000265	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	1.79e-05	0.000265	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GCGR—type 2 diabetes mellitus	1.74e-05	0.000257	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	1.67e-05	0.000247	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYTB—type 2 diabetes mellitus	1.64e-05	0.000243	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—OXCT1—type 2 diabetes mellitus	1.64e-05	0.000243	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	1.64e-05	0.000242	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SRD5A1—type 2 diabetes mellitus	1.6e-05	0.000236	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.53e-05	0.000226	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	1.53e-05	0.000226	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HSD17B3—type 2 diabetes mellitus	1.53e-05	0.000226	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—STAR—type 2 diabetes mellitus	1.53e-05	0.000226	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ACACA—type 2 diabetes mellitus	1.53e-05	0.000226	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCC8—type 2 diabetes mellitus	1.46e-05	0.000216	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CBS—type 2 diabetes mellitus	1.46e-05	0.000216	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC5A2—type 2 diabetes mellitus	1.41e-05	0.000208	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—COX2—type 2 diabetes mellitus	1.41e-05	0.000208	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	1.41e-05	0.000208	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	1.39e-05	0.000206	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NCOA6—type 2 diabetes mellitus	1.38e-05	0.000205	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.38e-05	0.000204	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HSD11B1—type 2 diabetes mellitus	1.36e-05	0.000201	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—UCP3—type 2 diabetes mellitus	1.36e-05	0.000201	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—UCP2—type 2 diabetes mellitus	1.36e-05	0.000201	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.34e-05	0.000198	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.34e-05	0.000198	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.32e-05	0.000195	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PCK1—type 2 diabetes mellitus	1.28e-05	0.000189	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.27e-05	0.000188	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.27e-05	0.000188	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.26e-05	0.000186	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.23e-05	0.000182	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.23e-05	0.000182	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.21e-05	0.000179	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HK1—type 2 diabetes mellitus	1.2e-05	0.000177	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.2e-05	0.000177	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	1.16e-05	0.000171	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GCKR—type 2 diabetes mellitus	1.16e-05	0.000171	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—KCNJ11—type 2 diabetes mellitus	1.16e-05	0.000171	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HSD3B2—type 2 diabetes mellitus	1.16e-05	0.000171	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—LPA—type 2 diabetes mellitus	1.16e-05	0.000171	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.12e-05	0.000165	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.12e-05	0.000165	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.11e-05	0.000164	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	1.11e-05	0.000164	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.08e-05	0.00016	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.08e-05	0.00016	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.08e-05	0.00016	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.08e-05	0.00016	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.08e-05	0.00016	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.08e-05	0.000159	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.06e-05	0.000156	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.05e-05	0.000155	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.04e-05	0.000154	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	1.03e-05	0.000152	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	9.88e-06	0.000146	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	9.88e-06	0.000146	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	9.63e-06	0.000142	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	9.63e-06	0.000142	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	9.57e-06	0.000141	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	9.44e-06	0.000139	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	9.44e-06	0.000139	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	9.25e-06	0.000137	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	9.2e-06	0.000136	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	9.2e-06	0.000136	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	9.2e-06	0.000136	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	9.2e-06	0.000136	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	9.18e-06	0.000136	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	9.18e-06	0.000136	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	9.18e-06	0.000136	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	9.14e-06	0.000135	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	8.98e-06	0.000133	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	8.87e-06	0.000131	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	8.81e-06	0.00013	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	8.81e-06	0.00013	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	8.62e-06	0.000127	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	8.48e-06	0.000125	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	8.48e-06	0.000125	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	8.33e-06	0.000123	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	8.27e-06	0.000122	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	8.25e-06	0.000122	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	8.25e-06	0.000122	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	8.25e-06	0.000122	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	8.19e-06	0.000121	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	8.19e-06	0.000121	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	8.19e-06	0.000121	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	8.1e-06	0.00012	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	8.02e-06	0.000119	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.91e-06	0.000117	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	7.85e-06	0.000116	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	7.7e-06	0.000114	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	7.54e-06	0.000111	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	7.46e-06	0.00011	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	7.46e-06	0.00011	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	7.27e-06	0.000107	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	7.24e-06	0.000107	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	7.21e-06	0.000106	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	7.15e-06	0.000106	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	7.15e-06	0.000106	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.96e-06	0.000103	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.96e-06	0.000103	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.96e-06	0.000103	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.96e-06	0.000103	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.67e-06	9.86e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.2e-06	9.16e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.16e-06	9.1e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	6.16e-06	9.1e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	6.14e-06	9.06e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	6.05e-06	8.94e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	5.88e-06	8.68e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.79e-06	8.55e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	5.72e-06	8.44e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.67e-06	8.38e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.67e-06	8.38e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	5.61e-06	8.29e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.56e-06	8.22e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.53e-06	8.17e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.53e-06	8.17e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.53e-06	8.17e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.5e-06	8.12e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	5.49e-06	8.11e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	5.47e-06	8.09e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.4e-06	7.97e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.33e-06	7.88e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	5.33e-06	7.87e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	5.26e-06	7.78e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	5.05e-06	7.46e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.96e-06	7.33e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.96e-06	7.33e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.96e-06	7.33e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	4.96e-06	7.32e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.87e-06	7.19e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.82e-06	7.13e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	4.8e-06	7.09e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.72e-06	6.97e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	4.72e-06	6.97e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	4.7e-06	6.95e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	4.65e-06	6.87e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.54e-06	6.7e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.49e-06	6.62e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.49e-06	6.62e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.3e-06	6.35e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.3e-06	6.35e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	4.1e-06	6.05e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	4.02e-06	5.94e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	3.78e-06	5.59e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.71e-06	5.47e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.71e-06	5.47e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.69e-06	5.45e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	3.68e-06	5.44e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.64e-06	5.38e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.53e-06	5.22e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	3.52e-06	5.2e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	3.52e-06	5.2e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.44e-06	5.08e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.37e-06	4.98e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.3e-06	4.88e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.29e-06	4.86e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	3.22e-06	4.76e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.21e-06	4.74e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.17e-06	4.68e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.04e-06	4.49e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.98e-06	4.4e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.89e-06	4.26e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.84e-06	4.19e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.83e-06	4.18e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.8e-06	4.13e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.46e-06	3.64e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.42e-06	3.57e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.22e-06	3.27e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.12e-06	3.13e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.12e-06	3.13e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.94e-06	2.86e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.62e-06	2.39e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	9.74e-07	1.44e-05	CbGpPWpGaD
